GLENMARK LIFE SCIENCES
Back to Income Statement
|
GLENMARK LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,161 Cr | ₹2,123 Cr | ₹1,885 Cr | ₹1,537 Cr | ₹886 Cr |
What is the latest Revenue of GLENMARK LIFE SCIENCES ?
Year | Revenue |
---|---|
Mar2024 | ₹2,161 Cr |
Mar2023 | ₹2,123 Cr |
Mar2022 | ₹1,885 Cr |
Mar2021 | ₹1,537 Cr |
Mar2020 | ₹886 Cr |
How is Revenue of GLENMARK LIFE SCIENCES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,161 Cr | 1.79 | |
Mar2023 | ₹2,123 Cr | 12.63 | |
Mar2022 | ₹1,885 Cr | 22.63 | |
Mar2021 | ₹1,537 Cr | 73.43 | |
Mar2020 | ₹886 Cr | - |
Compare Revenue of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹12,403.7 Cr | -1.7% | -9.8% | 16.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,608.0 Cr | -3.9% | -6.7% | 11.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,383.0 Cr | -1.4% | 1.8% | 56.7% | Stock Analytics | |
CIPLA | ₹118,239.0 Cr | -0.6% | 1.7% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,187.7 Cr | -4.8% | -10.2% | -6.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹89,695.7 Cr | -5.4% | -8.9% | 0.6% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -1.7% |
-9.8% |
16.3% |
SENSEX | -0.3% |
0.1% |
4.9% |
You may also like the below Video Courses